classified into two groups based on TNM stage: early and advanced stage disease groups. PD-ECGF expressions in HCC tissues were immunohistologically examined.
Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia
β Scribed by Punnee Butthep; Saknarong Rummavas; Raewadee Wisedpanichkij; Sumalee Jindadamrongwech; Suthat Fucharoen; Ahnond Bunyaratvej
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 204 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We examined the effects of the proinflammatory cytokine, tumor necrosis factora (TNF,), on the expression of proteolytically activated thrombin receptor (PATR) in human umbilical vein endothelial cells (HUVEC). PATR mRNA and protein levels were measured in confluent HUVEC monolayers after challenge
Proliferation of endothelial cells is regulated by angiogenic and antiangiogenic factors whose actions are mediated by complex interactions of multiple signaling pathways. Both vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) stimulate cell proliferation and activa
## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the